Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Pharmaron Beijing Co., Ltd.
  6. Summary
    300759   CNE100003JW4

PHARMARON BEIJING CO., LTD.

(300759)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
06/18/2021 06/21/2021 06/22/2021 06/23/2021 06/24/2021 Date
195.83 207.97 211 213.32 208.86 Last
5083810 5074795 4122145 4604421 4508457 Volume
+3.82% +6.20% +1.46% +1.10% -2.09% Change
Estimated financial data (e)
Sales 2021 7 008 M 1 081 M 1 081 M
Net income 2021 1 543 M 238 M 238 M
Net cash position 2021 2 725 M 421 M 421 M
P/E ratio 2021 110x
Yield 2021 0,17%
Sales 2022 9 099 M 1 404 M 1 404 M
Net income 2022 2 035 M 314 M 314 M
Net cash position 2022 3 977 M 614 M 614 M
P/E ratio 2022 83,7x
Yield 2022 0,23%
Capitalization 141 B 21 759 M 21 737 M
EV / Sales 2021 19,7x
EV / Sales 2022 15,0x
Nbr of Employees -
Free-Float 82,7%
More Financials
Company
Pharmaron Beijing Co. is specialised in the research, development and manufacturing of small molecule drugs, cell therapies and gene therapies. Net sales break down by activity as follows: - laboratory services (63.3%); - manufacturing and control of chemistry (24.1%); - in vitro biology services (12.2%); Net sales are distributed geographically as follows: China (12.7%), Asia (4%), North America (58.8%),... 
More about the company
Ratings of Pharmaron Beijing Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about PHARMARON BEIJING CO., LTD.
06/20PHARMARON BEIJING† : Files for Hong Kong Bourse Listing of Renminbi, US Dollar B..
MT
06/09PHARMARON BEIJING† : Proposes Reduction of Registered Capital
MT
06/08Pharmaron Beijing Raising $600 Million From Sale of Renminbi, US Dollar Conve..
MT
05/13MSCI Adds Ganfeng Lithium, Ningxia Baofeng to Global Emerging Markets Index U..
MT
04/30PHARMARON BEIJING† : Closure of register of members for the first h shares class..
PU
04/29PHARMARON BEIJING† : First Quarter Profit Rockets 142%, Revenue Soars
MT
04/28PHARMARON BEIJING† : Reply Slip for the First H Shares Class Meeting of 2021
PU
04/28PHARMARON BEIJING† : Reply Slip for the Annual General Meeting of 2020 (Applicab..
PU
04/28PHARMARON BEIJING† : Form of Proxy for the First H Shares Class Meeting of 2021
PU
04/28PHARMARON BEIJING† : Form of Proxy for the Annual General Meeting of 2020 (Appli..
PU
04/28PHARMARON BEIJING† : Notice of the first h shares class meeting of 2021
PU
04/28PHARMARON BEIJING† : Notice of the annual general meeting of 2020
PU
04/28PHARMARON BEIJING† : Report of board & supervisory committee; financial statemen..
PU
03/28PHARMARON BEIJING† : Proposed reduction of registered capital and proposed amend..
PU
03/28PHARMARON BEIJING† : Annual results announcement for the year ended december 31,..
PU
More news
News in other languages on PHARMARON BEIJING CO., LTD.

- No features available -

More news
Stock Trading Strategies
PHARMARON BEIJING CO., LTD. - 2020
Towards the breakout of a major resistance level
BUY
More Stock Trading Analysis
Chart PHARMARON BEIJING CO., LTD.
Duration : Period :
Pharmaron Beijing Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHARMARON BEIJING CO., LTD.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Last Close Price 213,32 CNY
Average target price 185,44 CNY
Spread / Average Target -13,1%
EPS Revisions
Managers and Directors
NameTitle
Bo Liang Lou Chairman & Chief Executive Officer
Shing Chung Li Chief Financial Officer & Board Secretary
Kexin Yang Chairman-Supervisory Board & Vice President
Hua Yang Chief Scientific Officer
Xiao Qiang Lou Chief Operating Officer & Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
PHARMARON BEIJING CO., LTD.77.18%25 331
MODERNA, INC.102.97%88 882
LONZA GROUP AG14.06%52 367
IQVIA HOLDINGS INC.35.24%46 761
CELLTRION, INC.-21.59%32 903
SEAGEN INC.-10.43%28 797